MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Patterns of early-phase 18F-FP-CIT PET images and the risk of dementia conversion in Parkinson’s disease

S. Chung, P. Lee, Y. Kim, Y. Sohn (Yongin-si, Republic of Korea)

Meeting: 2022 International Congress

Abstract Number: 136

Keywords: Dementia, Parkinsonism, Positron emission tomography(PET)

Category: Parkinson's Disease: Neuroimaging

Objective: This study aims to investigate the prognostic relevance of the patterns of early-phase 18F-fluorinated N-3-fluoropropyl-2-beta-carboxymethoxy-3-beta-(4-iodophenyl) nortropane (18F-FP-CIT) positron emission tomography (PET) images in patients with Parkinson’s disease (PD).

Background: Some evidence suggests that early-phase 18F-FP-CIT PET images (i.e., images which are acquired within the first 10 minutes after the injection of 5 mCi [185 MBq] of 18F-FP-CIT) can provide information on the regional cerebral perfusion, which resembles 18F-Fludeoxyglucose PET images. In this study, we hypothesized that the patterns of early-phase 18F-FP-CIT PET images would be associated with cognitive prognosis in patients with PD.

Method: A total of 227 patients with early-stage PD who underwent 18F-FP-CIT PET scans were enrolled in this study. We visually divided the patients with PD into two groups according to the patterns of early-phase 18F-FP-CIT PET images: a group with posterior cortical hypoperfusion and a group without posterior cortical hypoperfusion. We then compared the risk of dementia conversion between the two groups during the follow-up period.

Results: Among 227 patients with PD, 81 (35.7%) patients exhibited posterior cortical hypoperfusion on early-phase 18F-FP-CIT PET scans. There were no significant differences between the two groups in age, sex, disease duration, years of education, Unified PD Rating Scale Part III scores, and Mini-Mental State Examination scores at initial assessment. Meanwhile, Cox regression analysis demonstrated that the PD group with posterior cortical hypoperfusion had a higher risk of developing dementia than the PD group without posterior cortical hypoperfusion (hazard ratio, 2.743; 95% confidence interval, 1.371−5.486; p = 0.004).

Conclusion: The results of this study suggest that early-phase 18F-FP-CIT PET images would provide additional information on future cognitive decline in patients with PD.

References: n/a

To cite this abstract in AMA style:

S. Chung, P. Lee, Y. Kim, Y. Sohn. Patterns of early-phase 18F-FP-CIT PET images and the risk of dementia conversion in Parkinson’s disease [abstract]. Mov Disord. 2022; 37 (suppl 2). https://www.mdsabstracts.org/abstract/patterns-of-early-phase-18f-fp-cit-pet-images-and-the-risk-of-dementia-conversion-in-parkinsons-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2022 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/patterns-of-early-phase-18f-fp-cit-pet-images-and-the-risk-of-dementia-conversion-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley